Agreements

* On July 3, 2013, ArcticZymes AS, a subsidiary of Biotec Pharmacon ASA, has announced that it has signed a supply agreement with GE Healthcare Life Sciences for the supply of products based on ArcticZymes’ unique heat-labile enzyme portfolio. ArcticZymes’ heat-labile enzyme portfolio comprises SAP (shrimp alkaline phosphatase), Cod-UNG, DNases and other nucleases, and kits for PCR decontamination and gDNA removal. These cold-adapted enzymes are particularly well suited for molecular biological research and diagnostic markets. This supply agreement adds GE Healthcare Life Sciences to an expanding customer base already counting leading industry names such as Affymetrix and New England Biolabs. No financial or other deal terms have been disclosed.